1. Home
  2. DRD vs CPRX Comparison

DRD vs CPRX Comparison

Compare DRD & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

HOLD

Current Price

$26.02

Market Cap

3.4B

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$22.54

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRD
CPRX
Founded
1895
2002
Country
South Africa
United States
Employees
3410
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.0B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
DRD
CPRX
Price
$26.02
$22.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$32.63
$35.00
AVG Volume (30 Days)
310.5K
1.0M
Earning Date
08-19-2026
05-06-2026
Dividend Yield
2.23%
N/A
EPS Growth
N/A
28.24
EPS
N/A
1.68
Revenue
N/A
$119,072,803.00
Revenue This Year
$34.35
$8.00
Revenue Next Year
$24.62
$9.77
P/E Ratio
$15.32
$13.28
Revenue Growth
N/A
16.39
52 Week Low
$13.08
$19.05
52 Week High
$39.37
$26.56

Technical Indicators

Market Signals
Indicator
DRD
CPRX
Relative Strength Index (RSI) 27.93 38.69
Support Level $23.26 $22.25
Resistance Level $30.91 $24.94
Average True Range (ATR) 1.22 0.69
MACD -0.91 -0.21
Stochastic Oscillator 3.35 12.84

Price Performance

Historical Comparison
DRD
CPRX

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: